Browsing by Keyword : PD-L1
Showing results 1 to 12 of 12
Pub Year | | Title | AJOU Author(s) |
2022 | | A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer | 고영화, 이수진 |
2010 | | Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity | 박선, 손성향, 심지현, 이은소 |
2022 | | Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms | 김석휘 |
2022 | | Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response | 김석휘 |
2021 | | Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer | 고영화, 한재호, 함석진 |
2019 | | Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer | 김영배, 이다근 |
2020 | | HIP1R Expression and Its Association with PD-1 Pathway Blockade Response in Refractory Advanced NonSmall Cell Lung Cancer: A Gene Set Enrichment Analysis | 고영화, 이현우, 한재호, 함석진 |
2023 | | Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma | 고영화, 박범희, 이현우, 한재호, 함석진 |
2024 | | Impact of senescence cell signature in patients with non-small cell carcinoma and melanoma receiving PD-L1/PD-1 inhibitors | 고영화, 이현우, 한재호, 함석진 |
2019 | | Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients | 고영화, 이현우, 정준호, 한재호, 함석진 |
2023 | | Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer | 고영화, 변혜은, 이현우, 한재호, 함석진 |
2024 | | Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma | 고영화, 이현우, 한재호, 함석진 |
1